Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2023 Filed May 10, 2023 20:22 UTC |
Volkart Carmen BDirector
|
GrantCommon Stock | 7,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-013617 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,151 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:18 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 786 | $18.65 | $14,658.98 |
DisclosureSEC source: 0001437749-23-013611 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,562 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 08-31-2021. F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:17 UTC |
PAULS ERICSenior VP, Sales
|
SaleCommon Stock | 550 | $18.55 | $10,199.92 |
DisclosureSEC source: 0001437749-23-013608 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,498 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-15-2021. F2 · price: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 1,391 | $14.10 | $19,613.10 |
DisclosureSEC source: 0001437749-23-005373 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,760 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:36 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 700 | $14.56 | $10,188.99 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,715 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 700 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.55 to $14.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:35 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 251 | $14.58 | $3,660.28 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 3 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,151 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 251 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.5813 to $14.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:34 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 135 | $14.58 | $1,968.30 |
DisclosureSEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 3 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,348 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:32 UTC |
PAULS ERICSenior VP, Sales
|
SaleCommon Stock | 72 | $14.54 | $1,046.83 |
DisclosureSEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 3 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,048 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 72 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.53 to $14.54 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:36 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 6,387 | $15.27 | $97,532.68 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,415 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 6,387 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.00 to $15.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:35 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 3,801 | $15.36 | $58,398.56 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,402 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 3,801 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.345 to $15.375 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:34 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 2,162 | $15.39 | $33,275.56 |
DisclosureSEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 2 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,483 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 2,162 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.3714 to $15.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:32 UTC |
PAULS ERICSenior VP, Sales
|
SaleCommon Stock | 1,401 | $15.33 | $21,477.33 |
DisclosureSEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 2 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,120 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:36 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 6,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,802 F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 6,482 PSUs. Of those earned PSUs, one-third, or 2,161 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 4,321 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:35 UTC |
Moen BrentChief Financial Officer
|
GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,203 F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 2,304 PSUs. Of those earned PSUs, one-third, or 768 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 1,536 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:34 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 962 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,645 F1 · shares: On May 5, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 962 PSUs. Of those earned PSUs, one-third, or 320 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 642 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:32 UTC |
PAULS ERICSenior VP, Sales
|
GrantCommon Stock | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004975 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,521 F1 · shares: On May 5, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 595 PSUs. Of those earned PSUs, one-third, or 198 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 397 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:43 UTC |
Volkart Carmen BDirector
|
GrantCommon Stock | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004566 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:42 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 52,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004565 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,320 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:40 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 16,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004564 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,683 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:40 UTC |
PAULS ERICSenior VP, Sales
|
GrantCommon Stock | 12,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004563 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,926 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 21:12 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 1,020 | $9.18 | $9,363.70 |
DisclosureSEC source: 0001437749-22-019830 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,707 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 20:56 UTC |
BURKE WILLIAM WDirector
|
PurchaseCommon Stock | 4,900 | $9.15 | $44,835.00 |
DisclosureSEC source: 0001437749-22-019396 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,436 F1 · price: Reflects the weighted average price of 4,900 shares of common stock of Tactile Systems Technology, Inc. purchased by the reporting person in multiple transactions on August 4, 2022 with sale prices ranging from $9.14 to $9.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 19, 2022 Filed May 23, 2022 22:41 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 1,100 | $10.12 | $11,132.00 |
DisclosureSEC source: 0001437749-22-013333 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,536 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:40 UTC |
Asbury Valerie L.Director
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011964 · rdgdoc.xml · nonDerivative · entry 1 Asbury Valerie L. · CIK 0001904264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,538 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:30 UTC |
BURKE WILLIAM WDirector
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011961 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,636 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:39 UTC |
Shafer David BrentDirector
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011963 · rdgdoc.xml · nonDerivative · entry 1 Shafer David Brent · CIK 0001728374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,538 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:30 UTC |
Dodd Sheri LouiseDirector
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011960 · rdgdoc.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,448 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:28 UTC |
Jain DeeptiDirector
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011959 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,448 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:24 UTC |
Huggenberger RaymondDirector
|
GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011955 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,036 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 999 | $13.04 | $13,022.56 |
DisclosureSEC source: 0001437749-22-011765 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,959 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 999 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2022 with sale prices ranging from $13.0219 to $13.064 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:29 UTC |
PAULS ERICSenior VP, Sales
|
SaleCommon Stock | 600 | $13.03 | $7,819.08 |
DisclosureSEC source: 0001437749-22-011759 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,299 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 600 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2022 with sale prices ranging from $13.0223 to $13.065 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:35 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 176 | $20.64 | $3,633.06 |
DisclosureSEC source: 0001437749-22-005696 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,899 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019. F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 1,632 | $20.33 | $33,179.38 |
DisclosureSEC source: 0001437749-22-005171 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,075 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 01:27 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 877 | $19.78 | $17,350.39 |
DisclosureSEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,727 F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 01:25 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 624 | $19.85 | $12,383.28 |
DisclosureSEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,707 F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:27 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 53,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,604 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:25 UTC |
Moen BrentChief Financial Officer
|
GrantCommon Stock | 29,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,331 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:21 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 16,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004751 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,958 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:20 UTC |
PAULS ERICSenior VP, Sales
|
GrantCommon Stock | 12,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004749 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,899 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:10 UTC |
Asbury Valerie L.Director
|
GrantCommon Stock | 2,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004613 · rdgdoc.xml · nonDerivative · entry 1 Asbury Valerie L. · CIK 0001904264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,435 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2022. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:08 UTC |
Shafer David BrentDirector
|
GrantCommon Stock | 2,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004610 · rdgdoc.xml · nonDerivative · entry 1 Shafer David Brent · CIK 0001728374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,435 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2022. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,391 | $0.00 Strike: $21.68 | $0.00 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 6 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,391 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,370 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 5 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,370 shares Expires 2023-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,994 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · derivative · entry 4 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,994 shares Expires 2022-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionCommon Stock | 6,391 | $21.68 | $138,556.88 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 3 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionCommon Stock | 14,370 | $10.00 | $143,700.00 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 2 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:03 UTC |
ROCHE KEVIN HDirector
|
Exercise / conversionCommon Stock | 4,994 | $0.68 | $3,395.92 |
DisclosureSEC source: 0001437749-21-023296 · rdgdoc.xml · nonDerivative · entry 1 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 20:17 UTC |
Moen BrentChief Financial Officer
|
Tax withholdingCommon Stock | 486 | $44.87 | $21,806.82 |
DisclosureSEC source: 0001437749-21-021567 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,205 F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 14:30 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 1,063 | $43.11 | $45,828.16 |
DisclosureSEC source: 0001437749-21-019032 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,667 F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units. F2 · price: Reflects the weighted average price of 1,063 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 6, 2021 with sale prices ranging from $43.10 to $43.1622 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2021 Filed Jul 7, 2021 20:05 UTC |
REUVERS DANIEL L.Director · President and CEO
|
SaleCommon Stock | 2,961 | $49.75 | $147,319.82 |
DisclosureSEC source: 0001437749-21-016567 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730 F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units. F2 · price: Reflects the weighted average price of 2,961 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on July 7, 2021 with sale prices ranging from $49.74 to $49.839 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.